-

Croma-Pharma GmbH expands its portfolio introducing pure HA

Hyaluronic acid without distraction

original pure HA - Fiole (Photo: Business Wire)

pure HA - Fiole (Photo: Business Wire)

LEOBENDORF, Austria--(BUSINESS WIRE)--Croma is always committed to deepening its product portfolio to support customers in their daily work. With pure HA, Croma has developed a highly concentrated liquid skin mask in a minimalistic formula containing 1.8% of hyaluronic acid to smooth, moisturize and revitalize the skin while boosting its natural hydration.

Containing ingredients normally used in medical and aesthetic practices, Croma wants to bring the usual high quality of pharma grade hyaluronic acid to skincare used at home. Pure and without distraction.

"With pure HA, we have developed a skincare product based on hyaluronic acid that complies with the high standards of our medical devices, complements our existing portfolio perfectly and underlines Croma's claim as an expert in hyaluronic acid", remarked Andreas Prinz, Managing Director of Croma.

With a silky, lightweight texture suitable for all skin types, pure HA aims to make the skin feel nourished and radiant. Produced in a sterile and high professional glass container, pure HA brings a pharmaceutical approach to skincare at home – from the experts of hyaluronic acid.

About Hyaluronic Acid

Hyaluronic acid is one of the most essential ingredients in skincare today. Hyaluronic acid revitalizes the skin and at the same time strengthens its natural moisture content. It optimizes the skin's elasticity, plumps the skin and improves the appearance of fine lines and wrinkles.

About Croma-Pharma GmbH

Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company that specializes in the industrial production of hyaluronic acid syringes for the fields of medical aesthetics, ophthalmology and orthopaedics. Croma currently runs 12 international sales companies and distributes its products in more than 70 countries. Within its global sales network, Croma focuses with own branded products on minimally invasive aesthetic medicine. Besides a broad range of HA fillers from the own production site, Croma markets PDO lifting threads, a Platelet Rich Plasma (PRP) system and innovative skincare technologies in its core strategic markets.

Contacts

CROMA-PHARMA GmbH
Stefanie Höhn
Global Director Communications
Cromazeile 2
A-2100 Leobendorf
Phone: +43 676 846868 190
Mail: stefanie.hoehn@croma.at
Web: www.croma.at

Industry:

Croma-Pharma GmbH

Release Summary
With pure HA, Croma has developed a highly concentrated liquid skin mask in a minimalistic formula containing 1.8% of hyaluronic acid.
Release Versions
EnglishSpanishPortugueseGermanFrenchItalianDutchPolish
Hashtags
#forcreatorsofbeauty
#pureHA
#skincare

Contacts

CROMA-PHARMA GmbH
Stefanie Höhn
Global Director Communications
Cromazeile 2
A-2100 Leobendorf
Phone: +43 676 846868 190
Mail: stefanie.hoehn@croma.at
Web: www.croma.at

Social Media Profiles
https://www.facebook.com/CromaPharmaInternational
More News From Croma-Pharma GmbH

Croma-Pharma Completed the Decentralized Procedure for Its Botulinum Toxin to Treat Glabellar (frown) Lines

LEOBENDORF, Austria--(BUSINESS WIRE)--Croma-Pharma (Croma), today announced that the decentralized procedure for its botulinum toxin to gain market authorization in Europe has been accomplished. This important step is the basis to complete Croma’s already comprehensive portfolio. Croma’s botulinum toxin submission in Europe is based on the data of 3 completed randomized, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US. National phases to grant...

Croma-Pharma Expands Successful Mask Range With Face Masks for Different Areas of Application

LEOBENDORF, Austria--(BUSINESS WIRE)--Croma-Pharma (Croma) announced today the expansion of its successful mask portfolio. The carefully selected ingredients of each formulation, as well as the sheet material, are tailored to specific application areas and skin needs. The products have a pleasant texture and are suitable for all skin types. The right mask for every need The Croma mask portfolio offers two full face masks, as well as masks for specific areas of the face including the eyes, lips,...

Croma-Pharma Presents juvenus, a New Polynucleotide Based Injectable for Skin Hydration and Tissue Elasticity Restoration

LEOBENDORF, Austria--(BUSINESS WIRE)--Croma-Pharma (Croma) today announced the addition of juvenus to its product portfolio. It is an injectable, elastic, colourless and reabsorbable gel, based on polymerized polynucleotides (PDRN)1,2 of natural origin, which hydrates the skin and restores tissue elasticity. juvenus is produced by a European certified manufacturer and distributed by Croma. In a first phase Croma will market the product within its network of affiliated sales companies (AT, FR, D...
Back to Newsroom